• Bergenin Modulates γδT17 Cells via PPARγ to Alleviate Psoria

  2026-07-24

  This study demonstrates that bergenin, a plant-derived PPARγ agonist, selectively suppresses pathogenic γδT17 cell activation in psoriasis by inducing PROX1 ubiquitination and degradation. The findings provide mechanistic insight into immunometabolic regulation and position bergenin as a potential natural therapeutic for inflammatory skin diseases.

• BIIE 0246: Reliable NPY Y2 Receptor Antagonist for Cell Assa

  2026-07-23

  This article addresses real-world challenges in cell viability, proliferation, and neuropeptide Y (NPY) pathway assays, focusing on the use of BIIE 0246 (SKU B6836) as a highly selective Y2 receptor antagonist. Integrating recent mechanistic insights and protocol considerations, we demonstrate how BIIE 0246 from APExBIO enhances experimental reproducibility, sensitivity, and confidence for biomedical researchers.

• 17-AAG (Tanespimycin): Applied Protocols for HSP90 Inhibitio

  2026-07-23

  17-AAG (Tanespimycin) empowers researchers to target HSP90 chaperone pathways, enabling precise degradation of oncogenic proteins and modulation of apoptosis. This article bridges cutting-edge findings on regulated cell death with actionable workflows, troubleshooting strategies, and advanced applications in cancer research.

• Anagliptin (SK-0403): Beyond DPP-4 Inhibition in Vascular Re

  2026-07-22

  Explore how Anagliptin (SK-0403) advances research into DPP-4 inhibition and vascular smooth muscle physiology. This in-depth review uncovers unique mechanisms and translational implications not covered elsewhere.

• Bay 11-7085: NF-κB Activation Inhibitor in Inflammation Rese

  2026-07-22

  Bay 11-7085 empowers researchers to dissect NF-κB-driven inflammation with precision, advancing models of neuroinflammation, endometriosis, and beyond. Its robust, irreversible mechanism and well-validated protocols set the benchmark for reproducibility in apoptosis and cell proliferation assays.

• PEI-Modified Laminarin Nanoparticles Enhance Vaccine Immunit

  2026-07-21

  This study introduces cationic Laminarin nanoparticles modified with polyethyleneimine (PEI) as a novel vaccine adjuvant for ovalbumin. The findings highlight improved antigen uptake, dendritic cell maturation, and robust humoral and cellular immune responses, offering a promising strategy for next-generation nanovaccine design.

• Q-VD-OPh Pan-Caspase Inhibitor: Applied Workflows & Insights

  2026-07-21

  Q-VD-OPh stands out as a potent, cell-permeable pan-caspase inhibitor enabling precise control of apoptosis in vitro and in vivo. This article delivers actionable experimental protocols, troubleshooting strategies, and translational perspectives for using Q-VD-OPh in apoptosis research, neurodegeneration modeling, and cell viability optimization.

• Angiotensin III: Mechanistic Leverage for Translational Disc

  2026-07-20

  This thought-leadership article explores Angiotensin III (human, mouse)—a potent RAAS peptide—as a next-generation probe for cardiovascular and emerging viral pathogenesis research. We dissect its mechanistic roles, experimental validation, and translational implications, and offer strategic guidance for researchers seeking to bridge bench, disease modeling, and clinical insights. Integrating recent findings on angiotensin peptide interactions with SARS-CoV-2 spike protein, we position Angiotensin III as a tool for breaking new ground across disciplines.

• Cyanine 3 Tyramide: Fluorescent Dye for Biomedical Research

  2026-07-20

  Cyanine 3 Tyramide empowers cutting-edge signal amplification in immunohistochemistry, in situ hybridization, and flow cytometry, enabling high-resolution molecular mapping even in challenging tissue types. Optimized for sensitive detection and reproducibility, this fluorescent dye stands out for experimental versatility and compatibility with advanced TSA workflows.

• Rhodamine B: High-Purity Fluorescent Dye for Tracing & Cell

  2026-07-19

  Rhodamine B (Basic Violet 10) is a benchmark xanthylium chloride dye used as a fluorescent probe for microscopy and environmental tracing. It offers high solubility, stability, and purity, making it a preferred choice for quantitative pesticide drift studies and advanced cell labeling. This review synthesizes the latest evidence and clarifies common workflow missteps.

• Directed Differentiation of hiPSCs into Corneal Endothelial

  2026-07-18

  This study presents a robust, chemically defined, serum-free protocol for directing human induced pluripotent stem cells (hiPSCs) to differentiate into corneal endothelial-like cells. By modulating TGF-β and Wnt/β-catenin signaling with small molecule inhibitors such as CHIR-99021, the approach addresses challenges in producing functional endothelial cells for regenerative ophthalmology.

• Trolox in Oxidative Injury Research: Protocols and Best Prac

  2026-07-17

  Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) stands out as a gold-standard antioxidant for oxidative injury research, serving as both a benchmarking control and an experimental modulator. Discover how precise workflow design, data-driven protocol parameters, and troubleshooting strategies maximize Trolox’s value across high-throughput screening, neurodegeneration, and cancer biology applications.

• Pol II Degradation Triggers Apoptosis Beyond Transcription L

  2026-07-17

  This study uncovers that targeted degradation of RNA Polymerase II induces cell death through mechanisms independent of transcriptional arrest. The findings challenge previous assumptions about the link between transcription inhibition and apoptosis, with practical implications for interpreting HDAC inhibitor effects and designing apoptosis assays in cancer biology.

• Forskolin as a Precision Adenylate Cyclase Activator: Advanc

  2026-07-16

  Explore how Forskolin, a direct adenylate cyclase activator, enables advanced modeling of oxidative stress and trophoblast biology. This article uniquely bridges cAMP modulation with ferroptosis pathway insights for cutting-edge assay design.

• Tacrine Hydrochloride Hydrate in Alzheimer’s Disease Researc

  2026-07-16

  Tacrine hydrochloride hydrate (Tetrahydroaminacrine) remains the gold standard for benchmarking cholinesterase inhibition and neuroprotection in Alzheimer’s disease research. Here, we detail advanced protocols, troubleshooting strategies, and translational insights that make APExBIO’s Tacrine hydrochloride hydrate (SKU C6449) indispensable for reproducible neurodegenerative disease modeling.

462 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page